AI/ML Innovations Ownership
| AIMLF Stock | USD 0.05 0.01 18.30% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
AI/ML |
AI/ML OTC Stock Ownership Analysis
About 12.0% of the company shares are held by company insiders. The company last dividend was issued on the 12th of February 2020. AI/ML Innovations had 1:10 split on the 12th of February 2020. AIML Innovations Inc. operates in the digital healthcare business using artificial intelligence and machine learning . AIML Innovations Inc. was incorporated in 2009 and is headquartered in Toronto, Canada. AiMl Innovations is traded on OTC Exchange in the United States.The quote for AIML Innovations is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on AIML Innovations please contact Randy Duguay at 250-384-1999 or go to https://www.aiml-innovations.com.Currently Active Assets on Macroaxis
Other Information on Investing in AI/ML OTC Stock
AI/ML Innovations financial ratios help investors to determine whether AI/ML OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AI/ML with respect to the benefits of owning AI/ML Innovations security.